Teplizumab Preserves Beta Cells in New-Onset Type 1 Diabetes Teplizumab Preserves Beta Cells in New-Onset Type 1 Diabetes

Secondary endpoints including insulin use and glucose levels weren ' t met but trended in a positive direction.Medscape Medical News
Source: Medscape Diabetes Headlines - Category: Endocrinology Tags: Diabetes & Endocrinology News Source Type: news